Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
Home
Publications
CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
Authors:
FR
Fransje E. Reesink
Fransje E. Reesink
AL
Afina W. Lemstra
Afina W. Lemstra
KD
Karin D. van Dijk
Karin D. van Dijk
HB
Henk W. Berendse
Henk W. Berendse
WB
Wilma D.J. van de Berg
Wilma D.J. van de Berg
MK
Martin Klein
Martin Klein
MB
Marinus A. Blankenstein
Marinus A. Blankenstein
PS
Philip Scheltens
Philip Scheltens
MV
Marcel M. Verbeek
Marcel M. Verbeek
WF
Wiesje M. van der Flier
Wiesje M. van der Flier
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
28 September 2010
journal article
research article
Published by
SAGE Publications
in
Journal of Alzheimer’s Disease
Vol. 22
(1)
,
87-95
DOI:
10.3233/jad-2010-100186
PMID:
20847452
Abstract
In this study, we assessed whether cerebrospinal fluid (CSF) levels of the biomarker α-synuclein have a diagnostic value in differential diagnosis of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). We also analyzed associations between
Keywords
LEWY BODIES
DISCRIMINATE DEMENTIA
CSF Α-SYNUCLEIN
CSF
LEWY
ALZHEIMER
DLB
CEREBROSPINAL FLUID
DIFFERENTIAL DIAGNOSIS
DEMENTIA
Related articles
Cited
Cited by 84 articles
Scroll to top